How to Build a Clinical Trials Management App with Bubble

Building a clinical trials management app with Bubble addresses a real operational gap: most research sites manage protocol versions, participant records, adverse events, and IRB documents across disconnected spreadsheets and email threads. Commercial CTMS platforms charge $30,000–$100,000 or more per year, pricing out the majority of smaller sites entirely.

Bubble's relational data architecture, role-based access controls, and API Connector make it a credible platform for research organizations that need audit-ready clinical trial management at a cost proportionate to their budget.

Key Takeaways

• Core data types: Trial, Protocol, Participant, AdverseEvent, and IRBDocument are the five foundational data types.
• Enrollment workflows: Bubble conditionals enforce eligibility criteria screening before a Participant record moves to "Enrolled" status.
• Adverse event logging: Any serious adverse event triggers an immediate notification workflow to the principal investigator and safety monitor.
• Regulatory document storage: IRB approvals, consent forms, and protocol amendments live in Bubble's private file storage with version tracking.
• Blinding logic: Bubble privacy rules and conditional field visibility implement single-blind or double-blind data access restrictions without code.

Bubble App Development

Bubble Experts You Need

Hire a Bubble team that’s done it all—CRMs, marketplaces, internal tools, and more

Let's talk

What Is a Clinical Trials Management App — and Why Build It with Bubble?

A clinical trials management app consolidates trial protocol management, participant enrollment, visit data collection, adverse event reporting, and regulatory documentation in one system.

Common users include contract research organizations, academic medical centers, biotech sponsors, and independent research sites that need audit-ready documentation without enterprise software budgets.

• Protocol versioning: Track every amendment with version numbers, effective dates, approval status, and the document file, all linked to the parent Trial record.
• Multi-site management: Site records store principal investigator details, IRB approval status, enrollment targets, and activation dates for multi-site trial oversight.
• Audit-trail architecture: Bubble's data model supports immutable change logging for every participant record modification. This is a core 21 CFR Part 11 requirement.
• API Connector for eClinical integrations: Connect to ClinicalTrials.gov for NCT number validation and to external EDC systems via API without a middleware layer.

Teams focused on Bubble development for clinical research understand how to architect a CTMS that satisfies both research team workflows and regulatory documentation requirements.

What Features Should a Clinical Trials Management App Include?

A complete CTMS covers the full trial lifecycle from protocol setup through participant completion and regulatory reporting.

Scoping all features before starting prevents the most costly mid-build problem: adding 21 CFR Part 11 audit trail requirements after participant data is already in the system.

• Trial and protocol management: Create Trial records with phase, sites, sponsor, therapeutic area, primary endpoint, and overall status, with protocol version history linked.
• Protocol versioning: Maintain a full amendment history with version numbers, effective dates, approval status, and uploaded document files per version.
• Site management: Manage participating sites with PI contact, IRB approval date, activation status, and enrollment target per site.
• Participant enrollment: Screening log with eligibility checklist, consent tracking, randomization arm assignment, and consent document upload gating.
• Visit schedule and data collection: Per-protocol visit plan with CRF-style data entry forms per visit type, completeness checks, and data query generation for missing fields.
• Adverse event logging: Capture AE description, onset date, severity grade (1 through 5), causality assessment, serious AE flag, and reporting status with timeline tracking.
• IRB and regulatory document storage: Upload and version-control IRB submissions, approvals, consent forms, and protocol amendments in Bubble's private file storage.
• Monitoring and audit trail: Data entry timestamps, change history log, and query management for data discrepancies surfaced during monitoring visits.
• Reporting: Enrollment funnel by site, AE summary by severity and causality, protocol deviation log, and data completeness percentage by site.

The protocol deviation log and consent version tracking are the two features most commonly under-scoped. Both are required for routine monitoring visits and regulatory submissions.

How Do You Structure the Database for a Clinical Trials App in Bubble?

The Participant and AdverseEvent data types carry the highest regulatory weight in a CTMS build.

Build both with immutable event logging from day one. Amendments create new records, not edits to existing ones.

• Trial data type: Trial name, NCT number, phase option set, sponsor, therapeutic area, primary endpoint, and status option set (planning, active, closed, completed).
• Protocol data type: Trial reference, version number, effective date, amendment reason, status, and uploaded document file. One record per protocol version.
• Site data type: Trial reference, site name, principal investigator, IRB name, IRB approval date, activation status, and enrollment target per site.
• Participant data type: Site reference, trial reference, subject ID, screening date, eligibility status option set (screen fail, enrolled, withdrawn, completed), randomization arm, consent date, and consent document file.
• VisitRecord data type: Participant reference, visit name per protocol schedule, visit date, completed by (User), and data fields per visit type or linked CRF data type.
• AdverseEvent data type: Participant reference, AE description, onset date, severity grade option set (1–5), causality option set, serious AE boolean flag, reporting status, and resolved date.
• IRBDocument data type: Trial reference, document type option set, version number, submission date, approval date, and uploaded file attachment.
• DataQuery data type: VisitRecord reference, field in question, query text, status option set (open or resolved), raised by, raised date, and resolution notes.

Large multi-site trials should evaluate external database options for Bubble to handle Phase III data volumes without degrading query performance on worklist and monitoring views.

How Do You Build the Core Clinical Trial Workflows in Bubble?

Six workflows cover the complete CTMS cycle from protocol setup through blinding implementation and protocol amendments.

Build protocol setup and enrollment first. Adverse event logging and blinding logic come after you have validated that enrollment mechanics work correctly with your eligibility criteria rules.

• Protocol setup workflow: Trial coordinator creates a Trial record, adds the first Protocol record at version 1.0, creates Site records with PI assignments, and sets enrollment targets per site.
• Enrollment workflow: Coordinator enters screening data, eligibility checklist conditions are evaluated (all inclusion criteria must be met and no exclusion criteria flagged), Participant status sets to "Enrolled," randomization arm is assigned, and consent document upload is required before proceeding.
• Visit data collection: Coordinator selects a participant and opens the scheduled visit, completes the CRF-style form fields, a VisitRecord is created with a timestamp, and a completeness check triggers DataQuery creation for any required fields left blank.
• Adverse event workflow: User logs an AE, an AdverseEvent record is created, and if the serious AE flag is set to yes, an immediate SendGrid email goes to both the PI and safety monitor. If severity grade is 3 or higher, a 24-hour reporting deadline reminder is scheduled automatically.
• Protocol amendment workflow: Coordinator uploads a new protocol document version, a Protocol record is created with an incremented version number, and any active participants are flagged for re-consent if the amendment affects participant-facing procedures.
• Blinding logic: For double-blind trials, the randomization arm field is hidden from site staff via Bubble privacy rules based on user role. Only users assigned the unblinded safety monitor role can view the randomization arm data.

Never allow site staff to edit VisitRecord data after a monitoring query has been raised. Configure a lock workflow that prevents edits to VisitRecord fields with open DataQuery records until the query is resolved by a monitor.

What Security and Compliance Requirements Apply to Clinical Trials Apps?

Configuring data security for regulated Bubble apps properly is essential for a CTMS. Both 21 CFR Part 11 and HIPAA impose specific technical requirements on electronic clinical records.

A CTMS must satisfy three overlapping regulatory frameworks: HIPAA for participant PHI, 21 CFR Part 11 for electronic records in regulated research, and ICH GCP for good clinical practice documentation.

• Bubble Business plan required: Participant demographics, diagnoses, and medical history are PHI. The Business plan and a signed BAA from Bubble are mandatory before any participant data enters the system.
• 21 CFR Part 11 compliance: Electronic records and electronic signatures in clinical research must have audit trails, access controls, and be tamper-evident. Bubble's architecture supports this with proper privacy rule and ChangeLog configuration.
• Audit trail requirement: Every data entry and modification must log the user, timestamp, and change. Configure a ChangeLog data type triggered by any VisitRecord or AdverseEvent modification. Store old value, new value, field name, user, and datetime.
• Role hierarchy access control: Site staff, site PI, sponsor monitor, safety monitor, and system admin each require distinct privacy rule sets in Bubble. Never use a single shared role for multiple access levels.
• Informed consent version gating: The consent form version stored on the Participant record must match the current Protocol version. Bubble conditionals enforce this check before allowing enrollment to proceed.
• Data export integrity: All sponsor data exports must be reproducible and timestamped. Implement a DataExportLog data type to record every export event with user, datetime, filter criteria, and record count.

If your CTMS will be used for FDA-regulated trials, document your Bubble privacy rule configuration, ChangeLog architecture, and role definitions as part of your 21 CFR Part 11 compliance documentation.

What Plugins and Integrations Does a Clinical Trials App Need?

CTMS integrations cluster around regulatory documentation, participant communication, and electronic consent, with optional EDC system connections for more complex builds.

The DocuSign integration for electronic informed consent is the highest-priority optional integration. Electronic consent with timestamped records is increasingly expected in regulated trials.

• API Connector (built-in): ClinicalTrials.gov API for NCT number validation on Trial record creation, Medidata Rave or other EDC connections via REST API for data transfer.
• SendGrid plugin: Serious AE alerts to PI and safety monitor, protocol amendment notifications to site staff, and visit due-date reminders to coordinators.
• Twilio plugin: Urgent SMS alerts for serious adverse event reporting deadlines where email alone is insufficient for time-critical regulatory requirements.
• DocuSign API Connector: Electronic informed consent signature collection with timestamped records and a version reference linked to the current Protocol record.
• PDF Conjurer or Documenter plugin: Generate audit-ready data export PDFs, AE summary reports, enrollment status reports, and protocol deviation logs.
• Air File Uploader: IRB document and consent form uploads with version tracking and access control to prevent unauthorized document replacement.
• Bubble Scheduler: Automated visit due-date reminders to site staff, AE reporting deadline escalations for unresolved serious AEs, and nightly data completeness checks by site.

Budget for DocuSign API fees separately from your build cost. eConsent usage at multi-site trials with hundreds of participants generates meaningful transaction volume.

How Long Does It Take and What Does It Cost to Build a Clinical Trials App with Bubble?

Sponsors considering building a SaaS product with Bubble for a multi-client CTMS should design their data types with multi-tenancy from the start. Retrofitting tenant isolation is the most common and expensive CTMS rework.

Timeline and cost depend on the number of sites, trial phases, whether you need 21 CFR Part 11 audit trail implementation, and whether e-consent via DocuSign is in scope.

• Developer hourly rate: Experienced Bubble developers working on regulated clinical apps charge $100–$180/hour. 21 CFR Part 11 audit trail implementation adds 3–5 weeks of additional work compared to a standard healthcare app.
• DocuSign API fees: eConsent transaction fees at multi-site trials are a meaningful ongoing cost. Budget per-envelope fees based on your expected participant enrollment volume.
• ClinicalTrials.gov API: Free to use with no API key required. NCT number validation on trial creation adds zero marginal cost.
• Commercial CTMS comparison: Medidata Rave and Veeva Vault CTMS cost $30,000–$100,000 or more per year in licensing. A Bubble CTMS serves early-phase or single-indication sponsors at a fraction of that cost with equivalent core functionality.

A Bubble CTMS is most appropriate for Phase I and Phase II trials, single-indication sponsors, CROs with under 20 active studies, and academic sites that are currently managing trials in spreadsheets.

Conclusion

Bubble gives research organizations a configurable, audit-ready CTMS at a cost that smaller sites can actually justify, replacing spreadsheet-based trial management with proper data architecture.

The ChangeLog data type for 21 CFR Part 11 compliance, the serious AE notification chain, and consent version gating are the three components that determine whether your CTMS passes a monitoring visit.

Bubble App Development

Bubble Experts You Need

Hire a Bubble team that’s done it all—CRMs, marketplaces, internal tools, and more

Let's talk

Ready to Build Your Clinical Trials Management App on Bubble?

HIPAA, 21 CFR Part 11, and IRB documentation requirements must all be addressed in the data architecture before the first participant is enrolled. Adding compliance architecture after the fact is the most expensive rework in any CTMS build.

A poorly structured ChangeLog, missing consent version gating, or incorrect role-based privacy rules can disqualify data during a regulatory audit.

At LowCode Agency, we are a strategic product team, not a dev shop. We build HIPAA-compliant, audit-ready clinical applications including CTMS tools with 21 CFR Part 11-aware architecture, multi-site enrollment workflows, and serious AE alert automation.

• Scoping: We map your trial phases, site structure, eligibility criteria logic, AE reporting thresholds, and blinding requirements before any build work begins.
• Database design: We structure Trial, Protocol, Participant, AdverseEvent, IRBDocument, ChangeLog, and DataQuery data types for regulatory audit readiness.
• Workflow build: We configure protocol setup, enrollment gating, visit data collection, AE alerting, protocol amendment, and blinding workflows in Bubble.
• Plugin and API integration: We connect DocuSign for eConsent, SendGrid and Twilio for AE alerts, ClinicalTrials.gov for NCT validation, and any EDC system connections via API Connector.
• HIPAA and 21 CFR Part 11 compliance: We configure Business plan hosting, sign the BAA, implement ChangeLog architecture, and document your technical controls for regulatory submissions.
• Testing: We run enrollment eligibility tests, serious AE notification tests, blinding access control tests, and consent version gating verification before launch.
• Post-launch support: We provide ongoing support for protocol amendments, new site additions, AE reporting threshold changes, and regulatory documentation updates.

We have built 350+ products for clients including Coca-Cola, American Express, and Medtronic.

If you are ready to build your clinical trials management app with Bubble, let's scope it together.